Artificial Life, Inc. Company Profile

00:12 EDT 18th March 2018 | BioPortfolio

Artificial Life, Inc. is a pioneer in artificial intelligence and mobile technology. We are a public US corporation (public since 1998; NASDAQ OTC: ALIF) with global headquarters in Hong Kong. The Company has been founded in 1993 by our current CEO, Eberhard Schoeneburg, in Boston. We develop and sell a wide range of mobile products and are one of the leading providers of 3G content and technology in the world. To mention just two of many international awards: we have won the global Best Mobile Game Award by Ericsson and the Best Mobile Entertainment Software Award.


Suite 4601, China Online Centre, 333 Lockhart Road,
Hong Kong


Phone: (+852) 3102 2800
Fax: (+852) 3102 0690

News Articles [1109 Associated News Articles listed on BioPortfolio]

Artificial Eye: Researchers Combine Metalens with an Artificial Muscle

NewsResearchers have developed an adaptive metalens, that is essentially a flat, electronically controlled artificial eye. Contributed Author:&n

Artificial DNA Base Pair Expands Life's Vocabulary

Scientists have taken another step towards putting two additional letters in the dictionary of life to work. Researchers at the Scripps Institute have engineered cells to successfully transcribe a b...

Who's Who In Artificial Intelligence Drug Development

Artificial intelligence companies focused on the life science sector have boomed in the past decade. Many of these firms are...   

Artificial enzyme: Protein designed entirely from scratch functions in cells as a life-sustaining catalyst

(Nanowerk News) A dawning field of research, artificial biology, is working toward creating a genuinely new organism. At Princeton, chemistry professor Michael Hecht and the... Read More →

Will 'AI' Be Part of Your Health-Care Team?

TUESDAY, Dec. 12, 2017 -- Artificial intelligence is assuming a greater role in many walks of life, with research suggesting it may even help doctors diagnose disease. One new study suggests artificia...

Nearly half of life science professionals using AI - survey

Nearly half of life science professionals are using or experimenting with artificial intelligence (AI), according to a survey. Findings from the surveys in two webinars involving 374 senior pharma an...

Artificial Kidney Development Advances, Thanks to Collaboration by NIBIB Quantum Grantees

Creating an artificial implantable kidney would be an epic advance in medicine and could address a chronic shortage of donor kidneys needed for transplant. Researchers who have been at this quest for ...

Regenerative Artificial SkinEurope Market Status and Trend Report 20132023 [Report Updated: 16102017] Prices from USD $3480

Report SummaryRegenerative Artificial SkinEurope Market Status and Trend Report 20132023 offers a comprehensive analysis on Regenerative Artificial Skin industry, standing on the readers' perspective,...

Drugs and Medications [505 Associated Drugs and Medications listed on BioPortfolio]

Rx act gas relief [H E B]

HEB Gas Relief Drug Facts

Healthy accents gas relief [DZA Brands LLC]

DZA Brands, LLC Gas Relief Drug Facts

Topcare gas relief [Topco Associates LLC]

Topco Associates LLC. Gas Relief Drops Drug Facts

Babies r us gas relief [Toys"R"Us, Inc.]

Toys "R" Us, Inc. Infants' Gas Relief Drug Facts

Artificial tears [Cardinal Health]

Artificial Tears Solution Drug Facts

PubMed Articles [2011 Associated PubMed Articles listed on BioPortfolio]

ALife and Society: Editorial Introduction to the Artificial Life Conference 2016 Special Issue.

The Biological Foundations of Enactivism: A Report on a Workshop Held at Artificial Life XV.

This is a report on the Biological Foundations of Enactivism Workshop, which was held as part of Artificial Life XV. The workshop aimed to revisit enactivism's contributions to biology and to revitali...

Artificial Hydration at the End of Life.

Initiation or continuation of artificial hydration (AH) at the end of life requires unique considerations. A combination of ethical precedents and medical literature may provide clinical guidance on h...

Social Learning and Cultural Evolution in Artificial Life.

We describe the questions and discussions raised at the First Workshop on Social Learning and Cultural Evolution held at theArtificial Life Conference 2016 in Cancún, Mexico in July 2016. The purpose...

Robustness and Contingent History: From Prisoner's Dilemma to Gaia Theory.

In both social systems and ecosystems there is a need to resolve potential conflicts between the interests of individuals and the collective interest of the community. The collective interests need to...

Clinical Trials [2146 Associated Clinical Trials listed on BioPortfolio]

Withdrawal of Artificial Nutrition at the End of Life (PERCEPAL)

Withdrawing artificial nutrition in palliative care is an issue that often leads to ethical dilemmas among health care providers, despite clinical guidelines.

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear

Effectiveness of Artificial Balneotherapy, Phototherapy and Artificial Balneophototherapy in the Treatment of Psoriasis

The purpose of this study is to compare the effectiveness of artificial balneotherapy (AB), phototherapy (PT) and artificial balneophototherapy (BPT) in the treatment of plaque psoriasis, ...

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

The purpose of this study is to assess and compare the safetyness and efficacy of pilocarpine drops versus artificial saliva as symptomatic treatment for dry mouth and dry eyes caused by...

The Visual Effect of an Investigational Artificial Tear in the Tear Layer.

The purpose of this study is to investigate how the addition of a new artificial tear product when applied to the tear layer affects contrast sensitivity and optical aberrations over time....

Companies [1031 Associated Companies listed on BioPortfolio]

Life Time Foundation

As a private operating foundation of Life Time – The Healthy Way of Life CompanySM, the Life Time Foundation is on a mission to inspire healthy people and a healthy planet by...

Artificial Life, Inc.

Artificial Life, Inc. is a pioneer in artificial intelligence and mobile technology. We are a public US corporation (public since 1998; NASDAQ OTC: ALIF) with global headquarters in Hong Kong. The Com...

SynCardia Systems, Inc.

SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artifici...

SynCardia Systems, LLC

SynCardia Systems, LLC ( in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial ...

Artificial Cell Technologies, Inc.

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypep...

More Information about "Artificial Life, Inc." on BioPortfolio

We have published hundreds of Artificial Life, Inc. news stories on BioPortfolio along with dozens of Artificial Life, Inc. Clinical Trials and PubMed Articles about Artificial Life, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Artificial Life, Inc. Companies in our database. You can also find out about relevant Artificial Life, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record